“Knowing that his disease had a high cure rate, Ben Dacus felt a sense of security at a time of great uncertainty. In 1988 he was diagnosed with Hodgkin’s disease.
Strangely… [ Get More Details ]
According to the Pharmaceutical Research and Manufacturers of America, a medicine in development that is a monoclonal antibody, targets the epidermal growth factor receptor. Because cancer cells can become… [ Get More Details ]
The overall five-year survival rate for women with invasive breast cancer is now 89 percent.
[ Get More Details ]